Expression of Embryonic Stem Cell Marker Oct-4 and Its Prognostic Significance in Rectal Adenocarcinoma

Chun-gen Xing,Xue-guan Lu,Yong-sheng Zhang,Fang Zhou,Xiao-ping Xu

DOI: https://doi.org/10.1007/s11670-010-0106-8

2010-01-01

Chinese Journal of Cancer Research

Abstract:Objective Recent evidence suggests that Oct-4 is highly expressed in several cancers, and its expression contributes to tumor growth. In this study, we investigated the level of Oct-4 expression in rectal adenocarcinoma, and evaluated the prognostic significance of Oct-4 expression in these cases. Methods The immunohistochemical expression of Oct-4 was evaluated in 52 formalin-fixed paraffin-embedded postoperative rectal adenocarcinoma tissue samples. The impact of the immunoreactivity of Oct-4 in regard to clinical outcome was determined by Kaplan-Meier and log-rank. Results The expression level of Oct-4 ranged from 0 to 18.5%. There was no significant association between Oct-4 expression and gender ( P =0.772), age ( P =0.123), clinical stage ( P =0.391), and histological grade ( P =0.056). The 3-year local recurrence-free rates with negative and positive expression of Oct-4 were 83.5% and 75.0%, respectively ( P =0.583). The 3-year metastasis-free rates with negative and positive expression of Oct-4 were 88.6% and 61.9%, respectively ( P =0.035). The 3-year overall survival rates with negative and positive expression of Oct-4 were 77.9% and 49.0%, respectively ( P =0.037). Conclusion The results suggest that embryonic stem cell marker Oct-4 expression may have prognostic significance in patients with rectal adenocarcinoma. However, to confirm this more and larger studies are required.